News

Biogen (BIIB) delivered earnings and revenue surprises of +18.42% and +9.40%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

The fintech's membership surged 35% to 15.8 million and total loan originations hit a record $14.8 billion in the second quarter

Better-than-expected sales helped Biogen regain the support of investors, while AstraZeneca and GSK worked to convince Wall Street that they can hit ambitious revenue targets.

Medical device company Boston Scientific (NYSE:BSX) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 7.5% year on year to $5.44 billion. On the other hand, next quarter’s revenue guidance of $5.27 billion was less impressive, coming in 2.2% below analysts’ estimates. Its non-GAAP profit of $0.86 per share was 3.8% above analysts’ consensus estimates.

Vertiv (VRT) delivered earnings and revenue surprises of +6.29% and -3.41%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

KeyBanc expects Reddit’s investments in community engagement and advertising monetization to create a durable business capable of generating annual revenue growth above 30%.

United Microelectronics (NYSE:UMC) reported higher second-quarter revenue, wafer shipments and utilization as demand strengthened in communications and consumer applications, while the company raised its 2026 capital-expenditure budget to support silicon photonics and advanced-packaging growth initi

Ford Motor Company (NYSE:F) shares climbed more than 4% after the automaker reported better-than-expected second-quarter results and raised its financial outlook for the full year, supported by stronger operating performance across its core business. The company posted adjusted earnings per share of $0.

Investing.com -- Shares in Vertiv tumbled more than 9% in premarket trading Wednesday even as the data center equipment maker reported second-quarter earnings above estimates and raised its full-year guidance, with a revenue shortfall offseting the beat.

Musk's comments point to a hidden long-term advantage for the memory chip maker.

KLA Corporation (NASDAQ:KLAC) reported stronger-than-expected fiscal fourth-quarter results, but its shares fell more than 10% in pre-market trading on Wednesday after investors focused on a cautious near-term outlook and guidance that offered only limited upside. The semiconductor equipment manufacturer posted earnings per share of $1.

Vertiv stock drops sharply after the data-center infrastructure company’s second-quarter sales came in below Wall Street’s expectations.

Biogen’s growth portfolio, which includes one closely watched Alzheimer’s drug, is a bright spot in the second quarter.

Visa CEO Ryan McInerney says artificial intelligence is helping ‘shape the way work gets done.’ The payments giant reports earnings after the closing bell Tuesday.

There’s never a good time to miss on earnings, but memory-chip giant SK Hynix really picked its moment.

In recent days, Bristol Myers Squibb has been in focus as analysts updated earnings forecasts and a biotech partner sought approval for its first commercial product to be used alongside BMS’s cancer drug Opdivo. At the same time, commentators have highlighted Bristol Myers Squibb’s role as a dividend-oriented value name with a pipeline viewed as important for offsetting future patent expirations and evolving product sales trends. Building on this, we’ll explore how higher earnings...

Options traders expect a roughly $190 billion swing in Microsoft's market value after it reports earnings on Wednesday, an unusually large move that underscores investors' growing eagerness to see if billions of dollars in ‌AI spending are beginning to pay off. By comparison, over the last 12 earnings cycles, Microsoft has averaged a 4.8% implied move and a 4.4% actual move, Option Research & Technology Services (ORATS) data ​showed. The significantly higher pricing this quarter suggests that investors view Microsoft — one of the hyperscalers whose massive AI capital spending is at the heart of this year's AI rally and the broader bull market — as central to the AI earnings story.

Data center products and services company Vertiv (NYSE:VRT) fell short of the market’s revenue expectations in Q2 CY2026, but sales rose 24.1% year on year to $3.27 billion. On the other hand, next quarter’s outlook exceeded expectations with revenue guided to $3.75 billion at the midpoint, or 0.9% above analysts’ estimates. Its non-GAAP profit of $1.52 per share was 6.4% above analysts’ consensus estimates.

Tech giant Microsoft is set to report earnings today after the market close, and investors will be listening to hear whether the company expects to maintain the rapid growth at its cloud business, Azure. In its last quarterly earnings call, Microsoft said it expected roughly $190 billion in capex this calendar year, but the firm only spent about $30 billion in the first three months of the year. Microsoft shares closed up 1.1% yesterday, but they are 19% lower so far this year.

Meta stock has declined for nine consecutive sessions, falling about 13% cumulatively.

NXP Semiconductors has delivered a 33.5% total return over the past five years, yet its current checks suggest the stock now sits close to intrinsic value on a Discounted Cash Flow (DCF) basis while still looking attractive on earnings-based multiples. After the recent sector pullback, investors are weighing whether the latest weakness offers a reasonable entry point or simply reflects growing concerns about rising industry costs. Over the past five years, NXP Semiconductors has returned...

UBS Group (NYSE:UBS) reported second-quarter 2026 net profit of CHF 2.8 billion and earnings per share of CHF 0.87, as growth in wealth management and the investment bank helped lift underlying pre-tax profit by 45% from a year earlier to CHF 3.9 billion. Group Chief Executive Officer Sergio Ermott

Spotify Technology stock has delivered a very large 3 year return, yet the valuation signals today are split, with an intrinsic value estimate from a Discounted Cash Flow (DCF) model pointing to a discount while traditional market multiples suggest the shares trade at a premium. Spotify Technology has returned about 239.1% over the past 3 years, which puts recent share price weakness into context for anyone looking at the stock only over the last few months. Efforts to police fake streams...

Dillard's currently trades at $573.95 per share and has shown little upside over the past six months, posting a small loss of 4.9%. The stock also fell short of the S&P 500’s 6.3% gain during that period.

Investors are also watching for partnership or buyout catalysts as ImmunityBio expands Anktiva internationally and builds its global NK-cell platform.

SpaceX's growth vision remains entirely intact.

Microsoft stock, down earlier this year, is up 5.5% in the past month. The answers to three AI-related questions could determine whether shares continue to gain.

What a time it’s been for DaVita. In the past six months alone, the company’s stock price has increased by a massive 122%, reaching $235.17 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.

Meta could deliver a record quarter for its core advertising business. But Wall Street will look past that for the latest on the company’s AI spending.

Qualcomm will report its fiscal third-quarter results on Wednesday afternoon as it seeks to diversify away from mobile phones.